aluates Reports

$ 0.0

Automative

Global Quick-acting Asthma Medicine Market Research Report 2025

Published Date: July 2025

Report Code: QYRE-Auto-8B9006

Global Quick acting Asthma Medicine Market Outlook 2022

BUY CHAPTERS

Global Quick-acting Asthma Medicine Market Research Report 2025

Code: QYRE-Auto-8B9006

Report

July 2025

Pages:87

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Pfizer Inc

GlaxoSmithKline PLC

Novartis

Merck

Boehringer Ingelheim

Astrazeneca plc

Roche

Teva Pharmaceutical

Vectura Group

Quick-acting Asthma Medicine Market Size

The global market for Quick-acting Asthma Medicine was valued at US$ 23980 million in the year 2024 and is projected to reach a revised size of US$ 34020 million by 2031, growing at a CAGR of 5.2% during the forecast period.

Quick-acting Asthma Medicine Market

Quick-acting asthma medicine refers to a type of medication that provides immediate relief of asthma symptoms, particularly acute episodes of shortness of breath, wheezing, coughing, and chest tightness. These medications are also known as rescue or reliever inhalers. They work by relaxing the muscles around the airways and reducing inflammation, allowing the air passages to open up and making breathing easier.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Quick-acting Asthma Medicine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Quick-acting Asthma Medicine.

The Quick-acting Asthma Medicine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Quick-acting Asthma Medicine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Quick-acting Asthma Medicine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Quick-acting Asthma Medicine Market Report

Report Metric	Details
Report Name	Quick-acting Asthma Medicine Market
Accounted market size in year	US$ 23980 million
Forecasted market size in 2031	US$ 34020 million
CAGR	5.2%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Tablet Spray
Segment by Application	Hospital Pharmacy Online Pharmacy Retail Pharmacy Others
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Pfizer, GlaxoSmithKline, Novartis, Merck, Boehringer Ingelheim, AstraZeneca, Roche, Teva Pharmaceutical, Vectura Group
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Quick-acting Asthma Medicine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Quick-acting Asthma Medicine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Quick-acting Asthma Medicine Market growing?

Ans: The Quick-acting Asthma Medicine Market witnessing a CAGR of 5.2% during the forecast period 2025-2031.

What is the Quick-acting Asthma Medicine Market size in 2031?

Ans: The Quick-acting Asthma Medicine Market size in 2031 will be US$ 34020 million.

Who are the main players in the Quick-acting Asthma Medicine Market report?

Ans: The main players in the Quick-acting Asthma Medicine Market are Pfizer, GlaxoSmithKline, Novartis, Merck, Boehringer Ingelheim, AstraZeneca, Roche, Teva Pharmaceutical, Vectura Group

What are the Application segmentation covered in the Quick-acting Asthma Medicine Market report?

Ans: The Applications covered in the Quick-acting Asthma Medicine Market report are Hospital Pharmacy, Online Pharmacy, Retail Pharmacy, Others

What are the Type segmentation covered in the Quick-acting Asthma Medicine Market report?

Ans: The Types covered in the Quick-acting Asthma Medicine Market report are Tablet, Spray

Recommended Reports

Allergy & Asthma Drugs

Respiratory Treatments

Emergency & Immune Drugs

1 Quick-acting Asthma Medicine Market Overview

1.1 Product Definition

1.2 Quick-acting Asthma Medicine by Type

1.2.1 Global Quick-acting Asthma Medicine Market Value Comparison by Type (2024 VS 2031)

1.2.2 Tablet

1.2.3 Spray

1.3 Quick-acting Asthma Medicine by Application

1.3.1 Global Quick-acting Asthma Medicine Market Value by Application (2024 VS 2031)

1.3.2 Hospital Pharmacy

1.3.3 Online Pharmacy

1.3.4 Retail Pharmacy

1.3.5 Others

1.4 Global Quick-acting Asthma Medicine Market Size Estimates and Forecasts

1.4.1 Global Quick-acting Asthma Medicine Revenue 2020-2031

1.4.2 Global Quick-acting Asthma Medicine Sales 2020-2031

1.4.3 Global Quick-acting Asthma Medicine Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 Quick-acting Asthma Medicine Market Competition by Manufacturers

2.1 Global Quick-acting Asthma Medicine Sales Market Share by Manufacturers (2020-2025)

2.2 Global Quick-acting Asthma Medicine Revenue Market Share by Manufacturers (2020-2025)

2.3 Global Quick-acting Asthma Medicine Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of Quick-acting Asthma Medicine, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Quick-acting Asthma Medicine, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Quick-acting Asthma Medicine, Product Type & Application

2.7 Global Key Manufacturers of Quick-acting Asthma Medicine, Date of Enter into This Industry

2.8 Global Quick-acting Asthma Medicine Market Competitive Situation and Trends

2.8.1 Global Quick-acting Asthma Medicine Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Quick-acting Asthma Medicine Players Market Share by Revenue

2.8.3 Global Quick-acting Asthma Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Quick-acting Asthma Medicine Market Scenario by Region

3.1 Global Quick-acting Asthma Medicine Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global Quick-acting Asthma Medicine Sales by Region: 2020-2031

3.2.1 Global Quick-acting Asthma Medicine Sales by Region: 2020-2025

3.2.2 Global Quick-acting Asthma Medicine Sales by Region: 2026-2031

3.3 Global Quick-acting Asthma Medicine Revenue by Region: 2020-2031

3.3.1 Global Quick-acting Asthma Medicine Revenue by Region: 2020-2025

3.3.2 Global Quick-acting Asthma Medicine Revenue by Region: 2026-2031

3.4 North America Quick-acting Asthma Medicine Market Facts & Figures by Country

3.4.1 North America Quick-acting Asthma Medicine Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America Quick-acting Asthma Medicine Sales by Country (2020-2031)

3.4.3 North America Quick-acting Asthma Medicine Revenue by Country (2020-2031)

3.4.4 United States

3.4.5 Canada

3.5 Europe Quick-acting Asthma Medicine Market Facts & Figures by Country

3.5.1 Europe Quick-acting Asthma Medicine Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe Quick-acting Asthma Medicine Sales by Country (2020-2031)

3.5.3 Europe Quick-acting Asthma Medicine Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Quick-acting Asthma Medicine Market Facts & Figures by Region

3.6.1 Asia Pacific Quick-acting Asthma Medicine Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific Quick-acting Asthma Medicine Sales by Region (2020-2031)

3.6.3 Asia Pacific Quick-acting Asthma Medicine Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.7 Latin America Quick-acting Asthma Medicine Market Facts & Figures by Country

3.7.1 Latin America Quick-acting Asthma Medicine Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America Quick-acting Asthma Medicine Sales by Country (2020-2031)

3.7.3 Latin America Quick-acting Asthma Medicine Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Quick-acting Asthma Medicine Market Facts & Figures by Country

3.8.1 Middle East and Africa Quick-acting Asthma Medicine Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa Quick-acting Asthma Medicine Sales by Country (2020-2031)

3.8.3 Middle East and Africa Quick-acting Asthma Medicine Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Quick-acting Asthma Medicine Sales by Type (2020-2031)

4.1.1 Global Quick-acting Asthma Medicine Sales by Type (2020-2025)

4.1.2 Global Quick-acting Asthma Medicine Sales by Type (2026-2031)

4.1.3 Global Quick-acting Asthma Medicine Sales Market Share by Type (2020-2031)

4.2 Global Quick-acting Asthma Medicine Revenue by Type (2020-2031)

4.2.1 Global Quick-acting Asthma Medicine Revenue by Type (2020-2025)

4.2.2 Global Quick-acting Asthma Medicine Revenue by Type (2026-2031)

4.2.3 Global Quick-acting Asthma Medicine Revenue Market Share by Type (2020-2031)

4.3 Global Quick-acting Asthma Medicine Price by Type (2020-2031)

5 Segment by Application

5.1 Global Quick-acting Asthma Medicine Sales by Application (2020-2031)

5.1.1 Global Quick-acting Asthma Medicine Sales by Application (2020-2025)

5.1.2 Global Quick-acting Asthma Medicine Sales by Application (2026-2031)

5.1.3 Global Quick-acting Asthma Medicine Sales Market Share by Application (2020-2031)

5.2 Global Quick-acting Asthma Medicine Revenue by Application (2020-2031)

5.2.1 Global Quick-acting Asthma Medicine Revenue by Application (2020-2025)

5.2.2 Global Quick-acting Asthma Medicine Revenue by Application (2026-2031)

5.2.3 Global Quick-acting Asthma Medicine Revenue Market Share by Application (2020-2031)

5.3 Global Quick-acting Asthma Medicine Price by Application (2020-2031)

6 Key Companies Profiled

6.1 Pfizer

6.1.1 Pfizer Company Information

6.1.2 Pfizer Description and Business Overview

6.1.3 Pfizer Quick-acting Asthma Medicine Sales, Revenue and Gross Margin (2020-2025)

6.1.4 Pfizer Quick-acting Asthma Medicine Product Portfolio

6.1.5 Pfizer Recent Developments/Updates

6.2 GlaxoSmithKline

6.2.1 GlaxoSmithKline Company Information

6.2.2 GlaxoSmithKline Description and Business Overview

6.2.3 GlaxoSmithKline Quick-acting Asthma Medicine Sales, Revenue and Gross Margin (2020-2025)

6.2.4 GlaxoSmithKline Quick-acting Asthma Medicine Product Portfolio

6.2.5 GlaxoSmithKline Recent Developments/Updates

6.3 Novartis

6.3.1 Novartis Company Information

6.3.2 Novartis Description and Business Overview

6.3.3 Novartis Quick-acting Asthma Medicine Sales, Revenue and Gross Margin (2020-2025)

6.3.4 Novartis Quick-acting Asthma Medicine Product Portfolio

6.3.5 Novartis Recent Developments/Updates

6.4 Merck

6.4.1 Merck Company Information

6.4.2 Merck Description and Business Overview

6.4.3 Merck Quick-acting Asthma Medicine Sales, Revenue and Gross Margin (2020-2025)

6.4.4 Merck Quick-acting Asthma Medicine Product Portfolio

6.4.5 Merck Recent Developments/Updates

6.5 Boehringer Ingelheim

6.5.1 Boehringer Ingelheim Company Information

6.5.2 Boehringer Ingelheim Description and Business Overview

6.5.3 Boehringer Ingelheim Quick-acting Asthma Medicine Sales, Revenue and Gross Margin (2020-2025)

6.5.4 Boehringer Ingelheim Quick-acting Asthma Medicine Product Portfolio

6.5.5 Boehringer Ingelheim Recent Developments/Updates

6.6 AstraZeneca

6.6.1 AstraZeneca Company Information

6.6.2 AstraZeneca Description and Business Overview

6.6.3 AstraZeneca Quick-acting Asthma Medicine Sales, Revenue and Gross Margin (2020-2025)

6.6.4 AstraZeneca Quick-acting Asthma Medicine Product Portfolio

6.6.5 AstraZeneca Recent Developments/Updates

6.7 Roche

6.7.1 Roche Company Information

6.7.2 Roche Description and Business Overview

6.7.3 Roche Quick-acting Asthma Medicine Sales, Revenue and Gross Margin (2020-2025)

6.7.4 Roche Quick-acting Asthma Medicine Product Portfolio

6.7.5 Roche Recent Developments/Updates

6.8 Teva Pharmaceutical

6.8.1 Teva Pharmaceutical Company Information

6.8.2 Teva Pharmaceutical Description and Business Overview

6.8.3 Teva Pharmaceutical Quick-acting Asthma Medicine Sales, Revenue and Gross Margin (2020-2025)

6.8.4 Teva Pharmaceutical Quick-acting Asthma Medicine Product Portfolio

6.8.5 Teva Pharmaceutical Recent Developments/Updates

6.9 Vectura Group

6.9.1 Vectura Group Company Information

6.9.2 Vectura Group Description and Business Overview

6.9.3 Vectura Group Quick-acting Asthma Medicine Sales, Revenue and Gross Margin (2020-2025)

6.9.4 Vectura Group Quick-acting Asthma Medicine Product Portfolio

6.9.5 Vectura Group Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Quick-acting Asthma Medicine Industry Chain Analysis

7.2 Quick-acting Asthma Medicine Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Quick-acting Asthma Medicine Production Mode & Process Analysis

7.4 Quick-acting Asthma Medicine Sales and Marketing

7.4.1 Quick-acting Asthma Medicine Sales Channels

7.4.2 Quick-acting Asthma Medicine Distributors

7.5 Quick-acting Asthma Medicine Customer Analysis

8 Quick-acting Asthma Medicine Market Dynamics

8.1 Quick-acting Asthma Medicine Industry Trends

8.2 Quick-acting Asthma Medicine Market Drivers

8.3 Quick-acting Asthma Medicine Market Challenges

8.4 Quick-acting Asthma Medicine Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Pfizer Inc

GlaxoSmithKline PLC

Novartis

Merck

Boehringer Ingelheim

Astrazeneca plc

Roche

Teva Pharmaceutical

Vectura Group

List of Tables

Table 1. Global Quick-acting Asthma Medicine Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global Quick-acting Asthma Medicine Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global Quick-acting Asthma Medicine Market Competitive Situation by Manufacturers in 2024

Table 4. Global Quick-acting Asthma Medicine Sales (K Units) of Key Manufacturers (2020-2025)

Table 5. Global Quick-acting Asthma Medicine Sales Market Share by Manufacturers (2020-2025)

Table 6. Global Quick-acting Asthma Medicine Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global Quick-acting Asthma Medicine Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market Quick-acting Asthma Medicine Average Price (USD/Unit) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of Quick-acting Asthma Medicine, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Quick-acting Asthma Medicine, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Quick-acting Asthma Medicine, Product Type & Application

Table 12. Global Key Manufacturers of Quick-acting Asthma Medicine, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Quick-acting Asthma Medicine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Quick-acting Asthma Medicine as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Quick-acting Asthma Medicine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global Quick-acting Asthma Medicine Sales by Region (2020-2025) & (K Units)

Table 18. Global Quick-acting Asthma Medicine Sales Market Share by Region (2020-2025)

Table 19. Global Quick-acting Asthma Medicine Sales by Region (2026-2031) & (K Units)

Table 20. Global Quick-acting Asthma Medicine Sales Market Share by Region (2026-2031)

Table 21. Global Quick-acting Asthma Medicine Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global Quick-acting Asthma Medicine Revenue Market Share by Region (2020-2025)

Table 23. Global Quick-acting Asthma Medicine Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global Quick-acting Asthma Medicine Revenue Market Share by Region (2026-2031)

Table 25. North America Quick-acting Asthma Medicine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America Quick-acting Asthma Medicine Sales by Country (2020-2025) & (K Units)

Table 27. North America Quick-acting Asthma Medicine Sales by Country (2026-2031) & (K Units)

Table 28. North America Quick-acting Asthma Medicine Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America Quick-acting Asthma Medicine Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe Quick-acting Asthma Medicine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe Quick-acting Asthma Medicine Sales by Country (2020-2025) & (K Units)

Table 32. Europe Quick-acting Asthma Medicine Sales by Country (2026-2031) & (K Units)

Table 33. Europe Quick-acting Asthma Medicine Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe Quick-acting Asthma Medicine Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific Quick-acting Asthma Medicine Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific Quick-acting Asthma Medicine Sales by Region (2020-2025) & (K Units)

Table 37. Asia Pacific Quick-acting Asthma Medicine Sales by Region (2026-2031) & (K Units)

Table 38. Asia Pacific Quick-acting Asthma Medicine Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific Quick-acting Asthma Medicine Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America Quick-acting Asthma Medicine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America Quick-acting Asthma Medicine Sales by Country (2020-2025) & (K Units)

Table 42. Latin America Quick-acting Asthma Medicine Sales by Country (2026-2031) & (K Units)

Table 43. Latin America Quick-acting Asthma Medicine Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America Quick-acting Asthma Medicine Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa Quick-acting Asthma Medicine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa Quick-acting Asthma Medicine Sales by Country (2020-2025) & (K Units)

Table 47. Middle East and Africa Quick-acting Asthma Medicine Sales by Country (2026-2031) & (K Units)

Table 48. Middle East and Africa Quick-acting Asthma Medicine Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa Quick-acting Asthma Medicine Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global Quick-acting Asthma Medicine Sales (K Units) by Type (2020-2025)

Table 51. Global Quick-acting Asthma Medicine Sales (K Units) by Type (2026-2031)

Table 52. Global Quick-acting Asthma Medicine Sales Market Share by Type (2020-2025)

Table 53. Global Quick-acting Asthma Medicine Sales Market Share by Type (2026-2031)

Table 54. Global Quick-acting Asthma Medicine Revenue (US$ Million) by Type (2020-2025)

Table 55. Global Quick-acting Asthma Medicine Revenue (US$ Million) by Type (2026-2031)

Table 56. Global Quick-acting Asthma Medicine Revenue Market Share by Type (2020-2025)

Table 57. Global Quick-acting Asthma Medicine Revenue Market Share by Type (2026-2031)

Table 58. Global Quick-acting Asthma Medicine Price (USD/Unit) by Type (2020-2025)

Table 59. Global Quick-acting Asthma Medicine Price (USD/Unit) by Type (2026-2031)

Table 60. Global Quick-acting Asthma Medicine Sales (K Units) by Application (2020-2025)

Table 61. Global Quick-acting Asthma Medicine Sales (K Units) by Application (2026-2031)

Table 62. Global Quick-acting Asthma Medicine Sales Market Share by Application (2020-2025)

Table 63. Global Quick-acting Asthma Medicine Sales Market Share by Application (2026-2031)

Table 64. Global Quick-acting Asthma Medicine Revenue (US$ Million) by Application (2020-2025)

Table 65. Global Quick-acting Asthma Medicine Revenue (US$ Million) by Application (2026-2031)

Table 66. Global Quick-acting Asthma Medicine Revenue Market Share by Application (2020-2025)

Table 67. Global Quick-acting Asthma Medicine Revenue Market Share by Application (2026-2031)

Table 68. Global Quick-acting Asthma Medicine Price (USD/Unit) by Application (2020-2025)

Table 69. Global Quick-acting Asthma Medicine Price (USD/Unit) by Application (2026-2031)

Table 70. Pfizer Company Information

Table 71. Pfizer Description and Business Overview

Table 72. Pfizer Quick-acting Asthma Medicine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 73. Pfizer Quick-acting Asthma Medicine Product

Table 74. Pfizer Recent Developments/Updates

Table 75. GlaxoSmithKline Company Information

Table 76. GlaxoSmithKline Description and Business Overview

Table 77. GlaxoSmithKline Quick-acting Asthma Medicine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 78. GlaxoSmithKline Quick-acting Asthma Medicine Product

Table 79. GlaxoSmithKline Recent Developments/Updates

Table 80. Novartis Company Information

Table 81. Novartis Description and Business Overview

Table 82. Novartis Quick-acting Asthma Medicine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 83. Novartis Quick-acting Asthma Medicine Product

Table 84. Novartis Recent Developments/Updates

Table 85. Merck Company Information

Table 86. Merck Description and Business Overview

Table 87. Merck Quick-acting Asthma Medicine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 88. Merck Quick-acting Asthma Medicine Product

Table 89. Merck Recent Developments/Updates

Table 90. Boehringer Ingelheim Company Information

Table 91. Boehringer Ingelheim Description and Business Overview

Table 92. Boehringer Ingelheim Quick-acting Asthma Medicine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 93. Boehringer Ingelheim Quick-acting Asthma Medicine Product

Table 94. Boehringer Ingelheim Recent Developments/Updates

Table 95. AstraZeneca Company Information

Table 96. AstraZeneca Description and Business Overview

Table 97. AstraZeneca Quick-acting Asthma Medicine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 98. AstraZeneca Quick-acting Asthma Medicine Product

Table 99. AstraZeneca Recent Developments/Updates

Table 100. Roche Company Information

Table 101. Roche Description and Business Overview

Table 102. Roche Quick-acting Asthma Medicine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 103. Roche Quick-acting Asthma Medicine Product

Table 104. Roche Recent Developments/Updates

Table 105. Teva Pharmaceutical Company Information

Table 106. Teva Pharmaceutical Description and Business Overview

Table 107. Teva Pharmaceutical Quick-acting Asthma Medicine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 108. Teva Pharmaceutical Quick-acting Asthma Medicine Product

Table 109. Teva Pharmaceutical Recent Developments/Updates

Table 110. Vectura Group Company Information

Table 111. Vectura Group Description and Business Overview

Table 112. Vectura Group Quick-acting Asthma Medicine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 113. Vectura Group Quick-acting Asthma Medicine Product

Table 114. Vectura Group Recent Developments/Updates

Table 115. Key Raw Materials Lists

Table 116. Raw Materials Key Suppliers Lists

Table 117. Quick-acting Asthma Medicine Distributors List

Table 118. Quick-acting Asthma Medicine Customers List

Table 119. Quick-acting Asthma Medicine Market Trends

Table 120. Quick-acting Asthma Medicine Market Drivers

Table 121. Quick-acting Asthma Medicine Market Challenges

Table 122. Quick-acting Asthma Medicine Market Restraints

Table 123. Research Programs/Design for This Report

Table 124. Key Data Information from Secondary Sources

Table 125. Key Data Information from Primary Sources

Table 126. Authors List of This Report

List of Figures

Figure 1. Product Picture of Quick-acting Asthma Medicine

Figure 2. Global Quick-acting Asthma Medicine Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Quick-acting Asthma Medicine Market Share by Type: 2024 & 2031

Figure 4. Tablet Product Picture

Figure 5. Spray Product Picture

Figure 6. Global Quick-acting Asthma Medicine Market Value by Application (2020-2031) & (US$ Million)

Figure 7. Global Quick-acting Asthma Medicine Market Share by Application: 2024 & 2031

Figure 8. Hospital Pharmacy

Figure 9. Online Pharmacy

Figure 10. Retail Pharmacy

Figure 11. Others

Figure 12. Global Quick-acting Asthma Medicine Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 13. Global Quick-acting Asthma Medicine Market Size (2020-2031) & (US$ Million)

Figure 14. Global Quick-acting Asthma Medicine Sales (2020-2031) & (K Units)

Figure 15. Global Quick-acting Asthma Medicine Average Price (USD/Unit) & (2020-2031)

Figure 16. Quick-acting Asthma Medicine Report Years Considered

Figure 17. Quick-acting Asthma Medicine Sales Share by Manufacturers in 2024

Figure 18. Global Quick-acting Asthma Medicine Revenue Share by Manufacturers in 2024

Figure 19. Global 5 and 10 Largest Quick-acting Asthma Medicine Players: Market Share by Revenue in Quick-acting Asthma Medicine in 2024

Figure 20. Quick-acting Asthma Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 21. Global Quick-acting Asthma Medicine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 22. North America Quick-acting Asthma Medicine Sales Market Share by Country (2020-2031)

Figure 23. North America Quick-acting Asthma Medicine Revenue Market Share by Country (2020-2031)

Figure 24. United States Quick-acting Asthma Medicine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 25. Canada Quick-acting Asthma Medicine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 26. Europe Quick-acting Asthma Medicine Sales Market Share by Country (2020-2031)

Figure 27. Europe Quick-acting Asthma Medicine Revenue Market Share by Country (2020-2031)

Figure 28. Germany Quick-acting Asthma Medicine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 29. France Quick-acting Asthma Medicine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 30. U.K. Quick-acting Asthma Medicine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 31. Italy Quick-acting Asthma Medicine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 32. Russia Quick-acting Asthma Medicine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 33. Asia Pacific Quick-acting Asthma Medicine Sales Market Share by Region (2020-2031)

Figure 34. Asia Pacific Quick-acting Asthma Medicine Revenue Market Share by Region (2020-2031)

Figure 35. China Quick-acting Asthma Medicine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 36. Japan Quick-acting Asthma Medicine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 37. South Korea Quick-acting Asthma Medicine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 38. India Quick-acting Asthma Medicine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 39. Australia Quick-acting Asthma Medicine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. China Taiwan Quick-acting Asthma Medicine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 41. Indonesia Quick-acting Asthma Medicine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 42. Thailand Quick-acting Asthma Medicine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 43. Malaysia Quick-acting Asthma Medicine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 44. Latin America Quick-acting Asthma Medicine Sales Market Share by Country (2020-2031)

Figure 45. Latin America Quick-acting Asthma Medicine Revenue Market Share by Country (2020-2031)

Figure 46. Mexico Quick-acting Asthma Medicine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 47. Brazil Quick-acting Asthma Medicine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 48. Argentina Quick-acting Asthma Medicine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 49. Middle East and Africa Quick-acting Asthma Medicine Sales Market Share by Country (2020-2031)

Figure 50. Middle East and Africa Quick-acting Asthma Medicine Revenue Market Share by Country (2020-2031)

Figure 51. Turkey Quick-acting Asthma Medicine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 52. Saudi Arabia Quick-acting Asthma Medicine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 53. UAE Quick-acting Asthma Medicine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 54. Global Sales Market Share of Quick-acting Asthma Medicine by Type (2020-2031)

Figure 55. Global Revenue Market Share of Quick-acting Asthma Medicine by Type (2020-2031)

Figure 56. Global Quick-acting Asthma Medicine Price (USD/Unit) by Type (2020-2031)

Figure 57. Global Sales Market Share of Quick-acting Asthma Medicine by Application (2020-2031)

Figure 58. Global Revenue Market Share of Quick-acting Asthma Medicine by Application (2020-2031)

Figure 59. Global Quick-acting Asthma Medicine Price (USD/Unit) by Application (2020-2031)

Figure 60. Quick-acting Asthma Medicine Value Chain

Figure 61. Channels of Distribution (Direct Vs Distribution)

Figure 62. Bottom-up and Top-down Approaches for This Report

Figure 63. Data Triangulation

Figure 64. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Rescue Inhaler Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Short Acting Beta Agonists Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Inhaled Asthma Medications Market Research Report 2024

Global Asthma Treatment Market Insights Forecast to 2030

Anti Asthma Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Asthma Devices Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Rescue and Maintenance Inhalers Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Asthma Immunotherapies Market Research Report 2024

Quick relief Asthma Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Asthma Inhalation Formulation Market Research Report 2024

Global Asthma Reliever Rescue Medications Market Research Report 2024

Global Oral Asthma Medications Market Research Report 2024

Global Instant Asthma Relief Device Market Research Report 2025

Smart Medication Inhalers Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Long Acting Beta Agonist Market Insights Forecast to 2030

Global Nebulizers Inhalers and Respirators for Asthma Treatment Market Research Report 2024

Air Inhaler Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Asthma Nebulizer Market Research Report 2025

Global Terbutaline Sulfate for Injection Market Research Report 2024

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions